Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06024668 · ClinicalTrials.gov registry record · NA
Simulated Walking With Multiplexing Prism for Field Expansion in Monocular Vision
A NA study of One Eye Blindness and Blind Left Eye, sponsored by Massachusetts Eye and Ear Infirmary.
- Active
- Registry status
- NA
- Development phase
- 1
- Enrollment target
- 1
- Study location
NCT06024668: Active NA study of One Eye Blindness and Blind Left Eye, sponsored by Massachusetts Eye and Ear Infirmary.
NCT06024668 is a NA study of One Eye Blindness and Blind Left Eye that is active but no longer recruiting, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06024668, a NA study of One Eye Blindness and Blind Left Eye, is active but no longer recruiting, sponsored by Massachusetts Eye and Ear Infirmary.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are developing an assistive device, known as multiplexing prism that expands the field of view for individuals with acquired monocular vision (loss of an eye). The investigators will test the efficacy of the prism in improving the detection of colliding pedestrians during a simulated walking task.
Conditions Studied
Interventions
- DEVICE Multiplexing Prism
Study Locations (1)
Massachusetts
- Schepens Eye Research Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2024-08-04 |
| Est. Completion | 2026-10-28 |
| Phase | NA |
What the registry record for NCT06024668 still lists
NCT06024668 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with One Eye Blindness appearing as the primary indexed condition, and to 1 intervention - of which Multiplexing Prism is the first listed.
NCT06024668 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06024668 about?
NCT06024668 is a clinical study titled "Simulated Walking With Multiplexing Prism for Field Expansion in Monocular Vision". The investigators are developing an assistive device, known as multiplexing prism that expands the field of view for individuals with acquired monocular vision (loss of an eye). The investigators will test the efficacy of the prism in improving the detection of colliding pedestrians during a simulat...
What is the current status of trial NCT06024668?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1 participants. The study started on 2024-08-04. Estimated completion is 2026-10-28.
What conditions does trial NCT06024668 study?
This clinical trial studies the following conditions: One Eye Blindness, Blind Left Eye, Blind Right Eye.
What interventions are being tested in trial NCT06024668?
The interventions under investigation include: Multiplexing Prism (DEVICE).
Who is sponsoring clinical trial NCT06024668?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06024668 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06024668's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI